Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell NewsThe ASTCT, CIBMTR, and the EBMT, jointly convened an expert panel to formulate consensus recommendations for role, timing, and sequencing of auto-, allo-hematopoietic cell transplantation, and chimeric antigen receptor T-cell therapy for patients with newly diagnosed and relapsed/refractory mantle cell lymphoma.
[Bone Marrow Transplantation]
6445212 TNY3R799 items 1 apa 0 default asc 1 165960 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-65d0c3e3df544d42ec1479af7b44fdda%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22TNY3R799%22%2C%22library%22%3A%7B%22id%22%3A6445212%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Munshi%20et%20al.%22%2C%22parsedDate%22%3A%222021-08-20%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EMunshi%2C%20P.%20N.%2C%20Hamadani%2C%20M.%2C%20Kumar%2C%20A.%2C%20Dreger%2C%20P.%2C%20Friedberg%2C%20J.%20W.%2C%20Dreyling%2C%20M.%2C%20Kahl%2C%20B.%2C%20Jerkeman%2C%20M.%2C%20Kharfan-Dabaja%2C%20M.%20A.%2C%20Locke%2C%20F.%20L.%2C%20Shadman%2C%20M.%2C%20Hill%2C%20B.%20T.%2C%20Ahmed%2C%20S.%2C%20Herrera%2C%20A.%20F.%2C%20Sauter%2C%20C.%20S.%2C%20Bachanova%2C%20V.%2C%20Ghosh%2C%20N.%2C%20Lunning%2C%20M.%2C%20Kenkre%2C%20V.%20P.%2C%20%26%23x2026%3B%20Fenske%2C%20T.%20S.%20%282021%29.%20ASTCT%2C%20CIBMTR%2C%20and%20EBMT%20clinical%20practice%20recommendations%20for%20transplant%20and%20cellular%20therapies%20in%20mantle%20cell%20lymphoma.%20%3Ci%3EBone%20Marrow%20Transplantation%3C%5C%2Fi%3E%2C%201%26%23x2013%3B11.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41409-021-01288-9%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41409-021-01288-9%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D6445212%26amp%3Bitem_key%3DTNY3R799%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22ASTCT%2C%20CIBMTR%2C%20and%20EBMT%20clinical%20practice%20recommendations%20for%20transplant%20and%20cellular%20therapies%20in%20mantle%20cell%20lymphoma%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pashna%20N.%22%2C%22lastName%22%3A%22Munshi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mehdi%22%2C%22lastName%22%3A%22Hamadani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ambuj%22%2C%22lastName%22%3A%22Kumar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Dreger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonathan%20W.%22%2C%22lastName%22%3A%22Friedberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martin%22%2C%22lastName%22%3A%22Dreyling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brad%22%2C%22lastName%22%3A%22Kahl%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mats%22%2C%22lastName%22%3A%22Jerkeman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mohamed%20A.%22%2C%22lastName%22%3A%22Kharfan-Dabaja%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Frederick%20L.%22%2C%22lastName%22%3A%22Locke%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mazyar%22%2C%22lastName%22%3A%22Shadman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brian%20T.%22%2C%22lastName%22%3A%22Hill%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sairah%22%2C%22lastName%22%3A%22Ahmed%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alex%20F.%22%2C%22lastName%22%3A%22Herrera%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Craig%20S.%22%2C%22lastName%22%3A%22Sauter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Veronika%22%2C%22lastName%22%3A%22Bachanova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nilanjan%22%2C%22lastName%22%3A%22Ghosh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%22%2C%22lastName%22%3A%22Lunning%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vaishalee%20P.%22%2C%22lastName%22%3A%22Kenkre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mahmoud%22%2C%22lastName%22%3A%22Aljurf%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kami%20J.%22%2C%22lastName%22%3A%22Maddocks%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20P.%22%2C%22lastName%22%3A%22Leonard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Manali%22%2C%22lastName%22%3A%22Kamdar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tycel%22%2C%22lastName%22%3A%22Phillips%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amanda%20F.%22%2C%22lastName%22%3A%22Cashen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20J.%22%2C%22lastName%22%3A%22Inwards%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anna%22%2C%22lastName%22%3A%22Sureda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonathon%20B.%22%2C%22lastName%22%3A%22Cohen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sonali%20M.%22%2C%22lastName%22%3A%22Smith%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carmello%22%2C%22lastName%22%3A%22Carlo-Stella%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bipin%22%2C%22lastName%22%3A%22Savani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephen%20P.%22%2C%22lastName%22%3A%22Robinson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20S.%22%2C%22lastName%22%3A%22Fenske%22%7D%5D%2C%22abstractNote%22%3A%22Autologous%20%28auto-%29%20or%20allogeneic%20%28allo-%29%20hematopoietic%20cell%20transplantation%20%28HCT%29%20are%20accepted%20treatment%20modalities%20for%20mantle%20cell%20lymphoma%20%28MCL%29.%20Recently%2C%20chimeric%20antigen%20receptor%20%28CAR%29%20T-cell%20therapy%20received%20approval%20for%20MCL%3B%20however%2C%20its%20exact%20place%20and%20sequence%20in%20relation%20to%20HCT%20is%20unclear.%20The%20ASTCT%2C%20CIBMTR%2C%20and%20the%20EBMT%2C%20jointly%20convened%20an%20expert%20panel%20to%20formulate%20consensus%20recommendations%20for%20role%2C%20timing%2C%20and%20sequencing%20of%20auto-%2C%20allo-HCT%2C%20and%20CAR%20T-cell%20therapy%20for%20patients%20with%20newly%20diagnosed%20and%20relapsed%5C%2Frefractory%20%28R%5C%2FR%29%20MCL.%20The%20RAND-modified%20Delphi%20method%20was%20used%20to%20generate%20consensus%20statements.%20Seventeen%20consensus%20statements%20were%20generated%3B%20in%20the%20first-line%20setting%20auto-HCT%20consolidation%20represents%20standard-of-care%20in%20eligible%20patients%2C%20whereas%20there%20is%20no%20clear%20role%20of%20allo-HCT%20or%20CAR%20T-cell%20therapy%2C%20outside%20of%20a%20clinical%20trial.%20In%20the%20R%5C%2FR%20setting%2C%20the%20preferential%20option%20is%20CAR%20T-cell%20therapy%20especially%20in%20MCL%20failing%20or%20intolerant%20to%20at%20least%20one%20Bruton%5Cu2019s%20tyrosine%20kinase%20inhibitor%2C%20while%20allo-HCT%20is%20recommended%20if%20CAR%20T-cell%20therapy%20has%20failed%20or%20is%20not%20feasible.%20In%20the%20absence%20of%20contemporary%20evidence-based%20data%2C%20the%20panel%20found%20RAND-modified%20Delphi%20methodology%20effective%20in%20providing%20a%20formal%20framework%20for%20developing%20consensus%20recommendations%20for%20the%20timing%20and%20sequence%20of%20cellular%20therapies%20for%20MCL.%22%2C%22date%22%3A%222021-08-20%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41409-021-01288-9%22%2C%22ISSN%22%3A%221476-5365%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.nature.com%5C%2Farticles%5C%2Fs41409-021-01288-9%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-08-23T17%3A29%3A10Z%22%7D%7D%5D%7D
Munshi, P. N., Hamadani, M., Kumar, A., Dreger, P., Friedberg, J. W., Dreyling, M., Kahl, B., Jerkeman, M., Kharfan-Dabaja, M. A., Locke, F. L., Shadman, M., Hill, B. T., Ahmed, S., Herrera, A. F., Sauter, C. S., Bachanova, V., Ghosh, N., Lunning, M., Kenkre, V. P., … Fenske, T. S. (2021). ASTCT, CIBMTR, and EBMT clinical practice recommendations for transplant and cellular therapies in mantle cell lymphoma. Bone Marrow Transplantation, 1–11. https://doi.org/10.1038/s41409-021-01288-9 Cite
